New cancer clinical trial: Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Published on: June 02, 2025 at 11:00AM
Conditions: Esophageal Cancer; Gastric (Stomach) Cancer; Gastric Adenocarcinoma; Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma; Esophageal Carcinoma; Gastric (Cardia, Body) Cancer
Interventions: Drug: Chemotherapy; Drug: Targeted Systemic Therapy; Drug: Immunotherapy; Procedure: Surgery; Radiation: Radiotherapy
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); UMC Utrecht
Not yet recruiting
https://ift.tt/gR0XK87 Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma